AZB, Amarchand effect pharma deal: Bagaria to give up stake in Millipore India

Bar&Bench News Network

Dec 08, 2009

The pharmaceutical sector witnessed a significant change of hands with the Bagaria family selling its stake in Millipore (India) Private Limited. Millipore India, a joint venture between Kemwell Pvt. Limited and Millipore Corporation, provides technology and services to biopharma companies. AZB, Mumbai, led by Managing Partner Zia Mody and Partner Kalpana Merchant, acted as the legal advisors to the Bangalore-based entrepreneur, Subhash Bagaria, in the sell out worth Rs. 270 crores ($58 million).

As a result of the acquisition, Millipore India has now become a fully owned subsidiary of U.S based Millipore Corporation, a leader in bioscience research and biopharmaceutical manufacturing.

Managing Partner Cyril Shroff of Amarchand Mangaldas, Mumbai, led the acquisition for Millipore Corporation, along with  Bangalore Partner, Arjun Lall. Amarchand's team also comprised Principal Associates Ganesh Prasad and Namrata Kolar, and Associate Sharad Moudgal.

 

Add to My Clips Print this Story Email this Story

 

Facebook LinkedIn MySpace Digg Del.icio.us twitter

Comments(0)




Be the first to post a comment 

Post Your Comment

Name* :

Location :

Email Id :

Comment * :

Notify me when there is a comment


 

Thank you. Comments are subject to moderation.